XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Collaborative Arrangements - Eisai Co., Ltd. - Narrative (Details) - USD ($)
3 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Alliance revenue - Lenvima | Licenses and Other      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Finite-lived intangible assets     $ 563,000,000
Eisai      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Amortization of intangible assets $ 81,000,000 $ 72,000,000  
Eisai | Alliance revenue - Lenvima | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Probable contingent payments 125,000,000 $ 125,000,000  
Liabilities $ 250,000,000    
Eligible future contingent sales-based milestone payments (up to)     2,300,000,000
Eligible future contingent regulatory milestone payments (up to)     0
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Eligible future contingent sales-based milestone payments (up to)     $ 0